Cyclosporin A prodrugs: Design, synthesis and biophysical properties

Journal of Peptide Research

Volumn 63, Issue 2, 2004, Pages 147-154

  Hamel, A R ^a   Hubler, F ^a   Carrupt, A ^a   Wenger, R M ^a   Mutter, M ^a  

^a EPFL   (Switzerland)

Author keywords

Cyclosporin A; Diketopiperazine release; Drug delivery; Prodrugs; Solubilization

Indexed keywords

CYCLOSPORIN A; DIPEPTIDE; PIPERAZINEDIONE; PRODRUG; PROLINE;

ALKYLATION; ARTICLE; BIOPHYSICS; CARBOXY TERMINAL SEQUENCE; CYCLIZATION; DRUG DESIGN; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL;

CYCLOSPORINE; MOLECULAR STRUCTURE; PRODRUGS;

EID: 1542511351     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3011.2003.00111.x     Document Type: Article

References (27)

1. Lawen, A., Dittmann, J., Schmidt, B., Riesner, D. & Kleinkauf, H. (1992) Enzymatic biosynthesis of cyclosporin A and analogues. Biochimie 74, 511-516.
2. Dittmann, J., Wenger, R.M., Kleinkauf, H. & Lawen, A. (1994) Mechanism of cyclosporin A biosynthesis. J. Biol. Chem. 269, 2841-2846.
3. Lawen, A. (1996) Biosynthesis and mechanism of action of cyclosporins. Prog. Med. Chem. 33, 53-97.
4. Traber, R., Hofmann, H. & Kobel, H. (1989) Cyclosporins - new analogs by precursor directed biosynthesis. J. Antibiot. 42, 591-597.
5. Kobel, H. & Traber, R. (1982) Directed biosynthesis of cyclosporins. Eur. J. Appl. Microbio. Biotech. 14, 237-240.
6. Wenger, R. (1984) Synthesis of cyclosporine: total syntheses of 'cyclosporin a' and 'cyclosporin h', two fungal metabolites isolated from species Tolypocladium inflatum Gams. Helv. Chim. Acta 67, 502-525.
7. Koyasu, S. & Matsuda, S. (2000) Mechanisms of action of cyclosporine. Immunopharmacology 47, 119-125.
8. Schreiber, S.L. (1991) Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251, 283-287.
9. Kallen, J., Mikol, V., Quesniaux, V.F.J., Walkinshaw, M.D., Schneider-Scherzer, E.S., Schörgendorfer, K., Weber, G. & Fliri, H.G. (1997) Cyclosporins: recent developments in biosynthesis, pharmacology and biology, and clinical applications. In Biotechnology, a Multivolume Comprehensive Treatise, Vol. 7 (Rehm, H.-J., Reed, G., Pühler, A. & vonDöhren, H., eds), VCH Verlagsgesellschaft, Weinheim, 535-591.
10. Tarr, B.D. & Yalkowsky, S.H. (1989) Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size. Pharm. Res. 6, 40-43.
11. Dunn, C.J., Wagstaff, A.J., Perry, C.M., Plosker, G.L. & Goa, K.L. (2001) Cyclosporin. An updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral) in organ transplantation. Drugs 61, 1957-2016.
12. Drewe, J., Beglinger, C. & Kissel, T. (1992) The absorption site of cyclosporin in the human gastrointestinal tract. Br. J. Clin. Pharmacol. 39-43.
13. Bundgaard, H. (1991) Novel chemical approaches in prodrug design. Drugs Future 16, 443-458.
14. Stella, V.J. & Oliyai, R. (1993) Prodrugs of peptides and proteins for improved formulation and delivery. Ann. Rev. Pharmacol. Toxicol. 32, 521-544.
15. Stella, V.J., Charman, W.N.A. & Naringrekar, V.H. (1985) Prodrugs. Do they have advantages in clinical practice? Drugs 29, 455-473.
16. Kessler, H., Kock, M., Wein, T. & Gehrke, M. (1990) Reinvestigation of the conformation of cyclosporin A in chloroform. Helv. Chim. Acta 73, 1818-1832.
17. Huai, Q., Kim, H.-Y., Liu, J.Y.Z., Mondragon, A., Liu, J.O. & Ke, H. (2002) Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. Proc. Natl. Acad. Sci. U S A 99, 12037-12042.
18. Wenger, R., Payne, T.G. & Schreier, M.H. (1985) Cyclosporine: chemistry, structure-activity relationships and mode of action. Prog. Clin. Biochem. Med. 3, 157-191.
19. Goolcharran, C. & Borchardt, R.T. (1998) Kinetics of diketopiperazine formation using model peptides. J. Pharm. Sci. 87, 283-288.
20. Fischer, P.M. (2003) Diketopiperazines in peptide and combinatorial chemistry. J. Pept. Sci. 9, 9-35.
21. Wipf, P., Li, W., Adeyeye, C.M., Rusnak, J.M. & Lazo, J.S. (1996) Synthesis of chemoreversible prodrugs of ara-C with variable time release profiles. Biological evaluation of their apoptotic activity. Bioorg. Med. Chem. 4, 1585-1596.
22. Wipf, P., Li, W. & Sekhar, V. (1991) Synthesis of chemoreversible prodrugs of ara-C. Bioorg. Med. Chem. Lett. 1, 745-750.
23. Rothbard, J.B., Garlington, S., Lin, Q., Kirschberg, T., Kreider, E., McGrane, P.L., Wender, P.A. & Khavari, P.A. (2000) Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat. Med. 6, 1253-1257.
24. Matsumoto, H., Sohma, Y., Kimura, T., Hayashi, Y. & Kiso, Y. (2001) Controlled drug release: new water soluble prodrugs of an anti-HIV protease inhibitor. Bioorg. Med. Chem. Lett. 11, 605-609.
25. Borchardt, R.T. & Cohen, L.A. (1972) Stereopopulation control. II. Rate enhancement of intramolecular nucleophilic displacement. J. Am. Chem. Soc. 94, 9166-9174.
26. Baumann, G., Zenke, G., Wenger, R., Hiestand, P., Quesniaux, V., Andersen, E. & Schreier, M.H. (1992) Molecular mechanisms of immunosuppression. J. Autoimmun. 5 (Suppl. A), 67-72.
27. Mattila, P.S., Ullman, S., Fiering, S., Emmel, E.A., McCutcheon, M., Crabtree, G.R. & Herzenberg, L.A. (1990) The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J. 9, 4425-4433.